TITLE
Imatinib effect on Philadelphia chromosome positive acute lymphoblastic leukemia cells

SUMMARY
Analysis of Ph+ ALL cell lines (BV-173, NALM-1, SUP-B15, and TOM1) treated with tyrosine kinase inhibitor (TKI) imatinib. Ph encodes oncogenic BCR-ABL1 tyrosine kinase, which defines a subset of ALL with an unfavorable prognosis. Results provide insight into TKI resistance mechanisms in Ph+ ALL.

ORGANISM
Homo sapiens

PLATFORM
GPL571 : [HG-U133A_2] Affymetrix Human Genome U133A 2.0 Array

CITATIONS
Duy C, Hurtz C, Shojaee S, Cerchietti L et al. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. Nature 2011 May 19;473(7347):384-8. PMID:Â  21593872

